Skip to content
Clinical Trials – home

MUDr. Kanderkova s.r.o.

Research site

Slovakia Cerveneho Kriza 62/30, 029 01 Namestovo, Slovakia

  • 2 trials recruiting
  • Type 2 diabetes mellitus · Obesity · Overweight
  • Adult patients

About Specializations

MUDr. Kanderkova s.r.o. in Namestovo, Slovakia specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, Overweight, Hypercholesterolaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The outpatient diabetology and metabolic disorders department at MUDr. Kanderkova s.r.o. concentrates on research in cardiovascular disease, with special attention to cholesterol‑related conditions.

  • Atherosclerotic cardiovascular disease
  • Hyperlipidemia
  • LDL‑C lowering therapies

Ongoing studies assess the safety and effectiveness of a new compound, AZD0780, designed to lower LDL‑C in adults at risk for heart attack, stroke, or other vascular events, aiming to improve preventive care.

Clinical Research Overview

At this Slovakian site, investigators are exploring therapeutic options for patients with high “bad” cholesterol and associated vascular risk.

  • Risk reduction for atherosclerotic disease
  • Management of elevated lipid levels
  • Evaluation of novel lipid‑lowering agents

The research program, based in Namestovo, benefits from focused patient care and close monitoring by a dedicated clinical investigator.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Cerveneho Kriza 62/30029 01 NamestovoSlovakia
Recruiting now
2 trials
Conditions studied
4

More sites in NamestovoSlovakia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Type 2 diabetes mellitus+2

Not yet recruiting

Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD6234
  • Sponsor:AstraZeneca AB

Hypercholesterolaemia

Not recruiting

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.